z-logo
open-access-imgOpen Access
Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila
Author(s) -
Guang-Ho Cha,
Sunhong Kim,
Jeehye Park,
Eunji Lee,
Myung-Jin Kim,
Sung Bae Lee,
JinMan Kim,
Jongkyeong Chung,
Kyoung Sang Cho
Publication year - 2005
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.0500346102
Subject(s) - parkin , dopaminergic , ubiquitin ligase , biology , dopamine , microbiology and biotechnology , pink1 , mutant , ubiquitin , tyrosine hydroxylase , neuroscience , genetics , parkinson's disease , medicine , gene , disease
Parkin, an E3 ubiquitin ligase, has been found to be responsible for autosomal recessive juvenile parkinsonism characterized primarily by selective loss of dopaminergic neurons with subsequent defects in movements. However, the molecular mechanisms underlying this neuron loss remain elusive. Here, we characterized Drosophila parkin loss-of-function mutants, which exhibit shrinkage of dopaminergic neurons with decreased tyrosine hydroxylase level and impaired locomotion. The behavioral defect of parkin mutant flies was partially restored by administering L-DOPA, and the dopamine level in the brains of parkin mutant flies was highly decreased. Intriguingly, we found that c-Jun N-terminal kinase (JNK) is strongly activated in the dopaminergic neurons of parkin mutants and that impaired dopaminergic neuron phenotypes are dependent on the activation of the JNK signaling pathway. In consistent with this, our epistatic analysis and mammalian cell studies showed that Parkin inhibits the JNK signaling pathway in an E3 activity-dependent manner. These results suggest that loss of Parkin function up-regulates the JNK signaling pathway, which may contribute to the vulnerability of dopaminergic neurons in Drosophila parkin mutants and perhaps autosomal recessive juvenile parkinsonism patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here